Tri-modality Mesothelioma Treatment Triples Survival Time in New Study
A comparison of chemotherapy alone versus surgery-based tri-modality treatment for mesothelioma shows patients who take the more aggressive path tend…
Paclitaxel May Prevent Metastatic Peritoneal Mesothelioma in High Risk People
Administering the chemotherapy drug paclitaxel directly into the abdomen of people with mesothelioma might offer a way to prevent metastatic…
Real-World Mesothelioma Patients Need New Systemic Treatments
The newest study on real-world mesothelioma patients illustrates the need for more ways to treat this devastating cancer. Many studies…
Which Mesothelioma Patients will Benefit from Second-Line Chemotherapy
Japanese oncologists say they have found a way to help predict which peritoneal mesothelioma patients are most likely to get…
Phase 3 Clinical Trial to Test Durvalumab for Mesothelioma
A potential new first-line immunotherapy treatment for mesothelioma is now recruiting patients for a phase 3 clinical trial. The trial…
Chemotherapy | Europe | Genetics | International | Research | Treatments
Chemoresistance in Mesothelioma: The Role of Genetics
A team of Swiss and German researchers have a theory about why so many mesothelioma patients experience chemoresistance. Chemotherapy is…
Maintenance Therapy with Gemcitabine Extends Mesothelioma Survival in Dutch Study
Dutch researchers say administering maintenance therapy with gemcitabine after chemotherapy may help mesothelioma patients live longer than supportive care alone. …
Canada | Chemotherapy | International | New Studies | Research | Treatments
Chemotherapy Resistance in Mesothelioma Patients: New Insights
Canadian cancer researchers have discovered what may be a key cause of chemotherapy resistance in mesothelioma and other types of…
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Research | Treatments
Induction Chemotherapy with Avastin Improves Mesothelioma Response in New Study
Mesothelioma patients who had induction chemotherapy with Avastin (bevacizumab) prior to surgery responded better than those who had only chemotherapy…
Focused Radiation After Chemotherapy May Improve Mesothelioma Survival
New research suggests that mesothelioma patients who have focused radiation after chemotherapy may live longer with slower disease progression than…